🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Austria
Clinical trial register · Austria

Studies with an Austrian investigative site

Every study on the ClinicalTrials.gov registry that lists a site in Austria and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 1573 matching records held by the registry are in this view. Synced 26 Sep 2026, 19:45 UTC
1573
Studies in scope
all four open statuses
850
Recruiting now
open to new participants
339
Lead sponsors
across recruiting studies
Top sites
Vienna 1005 Graz 506 Linz 438 Innsbruck 398 Salzburg 291
Narrow the register
Recruitment status
Phase
Lead sponsor
Medical University of Vienna148 Medical University of Graz86 AstraZeneca54 Medical University Innsbruck42 Novartis Pharmaceuticals41
Site location
Vienna1005 Graz506 Linz438 Innsbruck398 Salzburg291
All 97 locations
Target enrolment
to

Trials in this register

1573 of 1573 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Austria
Start
Recruiting
Efficacy and Safety of BT200 (Rondaptivon Pegol) in Patients With Type 2B Von Willebrand Disease
NCT07273721Von Willebrand Disease (VWD), Type 2
Medical University of Vienna
Phase 2
6
Vienna
2025-08-14
Recruiting
ABCSG 61 / TEODOR : Neoadjuvant TrEatment Optimization Driven by Circulating Tumor DNA and endOcrine Responsiveness
NCT07084558Early and Locally Advanced Breast Cancer
Austrian Breast & Colorectal Cancer Study Group
Not applicable
350
Vienna, Baden, Dornbirn, Feldkirch, Graz, Innsbruck, Linz, Salzburg
2025-08-13
Recruiting
Comparison of Four-Channel Functional Electrical Stimulation vs. One-Channel Electrical Stimulation on Moderate Arm/Hand Paresis in Subacute Stroke Patients
NCT07098572Moderate Arm Paresis, Ischemic Stroke
MED-EL Elektromedizinische Geräte GesmbH
Not applicable
44
Hermagor, Zirl, Linz
2025-08-12
By invitation
Transfemoral TAVI With or Without Coronary Angiogram in Patients With Severe Aortic Stenosis (PURE TAVI)
NCT06898086Severe Aortic Stenosis
Rede Optimus Hospitalar SA
Not applicable
620
Graz, Klagenfurt
2025-08-08
Recruiting
Intensive Care Unit-acquired Heart Failure in Critically Ill: the ICU-HF Study
NCT07094425Heart Failure, ICUAW
Charite University, Berlin, Germany
Observational
50
Vienna
2025-08-07
Recruiting
A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
NCT06952803Prostate Cancer
DrugsPrednisolone/Prednisone·Saruparib·Abiraterone
AstraZeneca
Phase 3
700
Graz, Innsbruck, Linz, Vienna
2025-08-06
Recruiting
Ivosidenib and Azacitidine With or Without Venetoclax in Adult Patients With Newly Diagnosed IDH1-Mutated AML or MDS/AML Considered Ineligible for Intensive Chemotherapy
NCT07075016Acute Myeloid Leukemia
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
227
Feldkirch, Salzburg, Vienna
2025-08-05
Not yet open
Improved Medication and Care to Achieve Lipid Targets After Carotid Surgery
NCT07064135Dyslipidaemias, Carotid Artery Stenoses
Barmherzige Brüder Linz
Not applicable
50
Linz
2025-08-04
Recruiting
PROtective Ventilation With FLOW-Controlled Ventilation
NCT06703814Postoperative Pulmonary Complications (PPCs), Feasibility Studies, Pilot Study
Cantonal Hospital of St. Gallen
Not applicable
100
Innsbruck
2025-08-02
Recruiting
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
NCT07044336Endometrial Cancer, Malignant Solid Tumour
DrugsAdriamycin·Taxol·Doxorubicin·Paclitaxel
AstraZeneca
Phase 3
800
Graz, Innsbruck, Vienna
2025-08-01
Recruiting
HOPE Against Cancer Recurrence in HCC
NCT06717919Liver Transplantation, HCC, Oncological Outcomes
Philipp Dutkowski
Phase 4
220
Innsbruck, Vienna
2025-08-01
Not yet open
A Blinded Randomized Clinical Study of RefluxStop™ Compared With Nissen Fundoplication in the Treatment of GERD
NCT07004400GERD (Gastroesophageal Reflux Disease)
Implantica CE Reflux Ltd.
Not applicable
200
Vienna
2025-08-01
Active, closed
A Study to Evaluate Tobevibart+Elebsiran in Participants With Chronic HDV Infection Not Virologically Suppressed With Bulevirtide
NCT07128550Viral Hepatitis
DrugsTobevibart·Bulevirtide·Elebsiran
Vir Biotechnology, Inc.
Phase 3
150
Innsbruck, Vienna
2025-07-30
Active, closed
A Registry on the FARAVIEW Technology of the OPAL HDx Mapping System When Used With the FARAWAVE NAV Ablation Catheter in the Treatment of Atrial Fibrillation
NCT06808217Atrial Fibrillation, Pulsed Field Ablation, FARAPULSE
Boston Scientific Corporation
Observational
550
Vienna
2025-07-30
Recruiting
A Study to Learn About the Safety and Effects of the Study Drug PRX-102 in Children and Adolescents With Fabry Disease
NCT06328608Fabry Disease
Chiesi Farmaceutici S.p.A.
Phase 2/3
22
Salzburg
2025-07-29
Recruiting
Phase 3, Open-label, Single-dose Study of CSL222 in Adolescent Male Subjects (≥ 12 to < 18 Years of Age) With Severe or Moderately Severe Hemophilia B
NCT07080905Hemophilia B
CSL Behring
Phase 3
20
Vienna
2025-07-28
Recruiting
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
NCT07037433Atherosclerotic Cardiovascular Disease, Overweight, Obesity
DrugMaridebart cafraglutide
Amgen
Phase 3
12,800
Feldkirch, Graz, Klagenfurt, Linz, Mattersburg, Vienna
2025-07-25
Recruiting
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
NCT06758401Non-Small Cell Lung Cancer, Carcinoma, Non-Small-Cell Lung, Carcinoma, Non-Small-Cell Lung (NSCLC)
DrugsSigvotatug vedotin·Pembrolizumab
Pfizer
Phase 3
714
Linz, Graz, Vienna
2025-07-23
Recruiting
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
NCT07064473Diabetes Mellitus, Type 2, Hypertension, Cardiovascular Diseases
DrugsVicadrostat·Dapagliflozin
Boehringer Ingelheim
Phase 3
11,800
Graz, Salzburg, Vienna
2025-07-22
Recruiting
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
NCT06943755Pancreatic Neuroendocrine Tumor (pNET), Extra-Pancreatic Neuroendocrine Tumor (epNET)
DrugsZanzalintinib·Everolimus
Exelixis
Phase 2/3
440
Graz, Salzburg, Vienna
2025-07-21
Recruiting
A Study Investigating the Effectiveness and Safety of Garadacimab for Treating Patients With Hereditary Angioedema (HAE)
NCT07001280Hereditary Angioedemas
CSL Behring
Observational
200
Linz
2025-07-21
Recruiting
Safety and Effectiveness of the Orsiro Mission 48-mm Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions
NCT06779630Coronary Artery Disease
Teleflex
Not applicable
150
Vienna, Graz
2025-07-18
Recruiting
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
NCT06765109Non-small Cell Lung Cancer, Anaplastic Lymphoma Kinase-positive
DrugsNeladalkib·Alectinib
Nuvalent Inc.
Phase 3
450
Vienna
2025-07-17
Recruiting
Amino Acid PET-based Response Assessment in IDH-mutant Gliomas (APPEAR)
NCT07159607IDH-mutant Glioma (Oligodendroglioma, Astrocytoma)
LMU Klinikum
Observational
100
Vienna
2025-07-17
Recruiting
Implantation of Engineered Cartilage Grafts for Treatment of Patellofemoral Osteoarthritis Versus Surgical Comparators.
NCT06576583Patellofemoral Osteoarthritis
DrugN-Tec
University Hospital, Basel, Switzerland
Phase 2
150
Vienna
2025-07-15
Recruiting
Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
NCT06891755COPD, Emphysema
Apreo Health, Inc.
Not applicable
250
Vienna
2025-07-15
Recruiting
A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
NCT06963827Kidney Disease
DrugMezagitamab
Takeda
Phase 3
347
Linz, Vienna
2025-07-15
Recruiting
A Study to Evaluate Patient-Reported Satisfaction, Effectiveness, and Safety of Atezolizumab in Participants Treated in Routine Clinical Practice
NCT07284121Lung Cancer, Hepatocellular Carcinoma
DrugAtezolizumab
Hoffmann-La Roche
Observational
700
Krems, Linz, Vienna, Wels
2025-07-15
Active, closed
A Study of CC-97540 (BMS-986353 or Zola-cel), CD19-Targeted NEX-T CAR T Cells, in Participants With Active SLE Despite Immunosuppressants (Breakfree-SLE)
NCT07015983Lupus Erythematosus, Systemic, Lupus Nephritis
DrugsZola-cel·Fludarabine·Cyclophosphamide
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Phase 2
89
Vienna, Salzburg
2025-07-14
Recruiting
ELEVATE-HFpEF Clinical Study
NCT06678841Heart Failure With Preserved Ejection Fraction (HFpEF)
Medtronic Cardiac Rhythm and Heart Failure
Not applicable
700
Linz
2025-07-09
Recruiting
Prevention of Desaturations Using Positive Airway Pressure or Capnometry During ERCP
NCT07056075Desaturation, Hypoxemia, ERCP
Karl Landsteiner University of Health Sciences
Not applicable
288
Graz, Sankt Pölten
2025-07-07
Recruiting
PREMEDICAL is a Clinical Investigation Aiming to Create a Data Basis That Can be Used to Enrich Information Collected in the Course of the Classic Patient Journey. Patients in the Emergency Department Will be Asked to Answer Patient-related and Symptom-oriented Questions. Minimum Age is 18 Years
NCT06933550Emergency Department Triage
XUND Solutions GmbH
Observational
3,000
Graz
2025-07-04
Active, closed
A Study of JSB462 (Luxdegalutamide) Plus Lutetium (177Lu) Vipivotide Tetraxetan in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)
NCT07047118Prostatic Cancer, Castration-Resistant
DrugsLuxdegalutamide·Pluvicto
Novartis Pharmaceuticals
Phase 2
138
Innsbruck, Linz, Vienna
2025-07-03
Recruiting
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
NCT07052903Transthyretin Amyloidosis With Cardiomyopathy
DrugNucresiran
Alnylam Pharmaceuticals
Phase 3
1,750
Braunau am Inn, Graz, Vienna, Wels
2025-07-02
Recruiting
Comparison of Two Different Methods for Calculating Intraocular Lens Tilt and Decentration
NCT07025707Intraocular Lens
St John of God Hospital, Vienna
Observational
15
Vienna
2025-07-01
Not yet open
Long-term Effect of Dupilumab in N-ERD
NCT07049978NSAID-Induced Asthma, NSAIDs Hypersensitivity, Chronic Rhinosinusitis (CRS), Asthma Bronchiale
Medical University of Vienna
Observational
30
Vienna
2025-07-01
Recruiting
Fighting Addictions, Improving Lives: COmprehensive Drug Rehabilitation With Music
NCT07028983Substance Use Disorder (SUD)
NORCE Norwegian Research Centre AS
Not applicable
600
Vienna
2025-07-01
Recruiting
I-WEAR: Evaluating Wearables and Health Summaries in ICU Survivors
NCT07035106Post-Intensive Care Syndrome (PICS), Critical Illness Recovery, Coronary Artery Disease
Ludwig Boltzmann Gesellschaft
Not applicable
60
Vienna
2025-07-01
By invitation
Implementation of the Pain Management Toolkit
NCT07157709Pain
Medizinische Universität Graz, Institut für Pflegewissenschaft
Not applicable
40
Graz
2025-07-01
Recruiting
Safety and Efficacy of T-DXd vs. CDK4/6i-based ET as First-line Therapy of HR-positive and HER2-low/Ultralow Advanced Breast Cancer Patients Classified as Non-luminal Subtype
NCT06486883Advanced Breast Cancer, Advanced Breast Carcinoma, Hormone Receptor Positive Breast Carcinoma
DrugsCDK4/6i·Trastuzumab deruxtecan
MedSIR
Phase 2
200
Graz, Linz, Vienna
2025-06-30
Active, closed
Rezafungin for Treatment of Chronic Pulmonary Aspergillosis (CPA) in Adults With Limited Treatment Options
NCT06794554Chronic Pulmonary Aspergillosis
Mundipharma Research Limited
Phase 2
60
Linz
2025-06-30
Recruiting
Repotrectinib in ROS1-positive Non-small Cell Lung Cancer Patients With Active Brain Metastasis
NCT06315010NSCLC, Brain Metastases, ROS1 Gene Rearrangement
DrugRepotrectinib
MedSIR
Phase 2
20
Graz, Vienna
2025-06-27
Recruiting
An Ecological Momentary Intervention for the Reduction of Impairment in Somatic Symptom Disorder
NCT07646509Somatic Symptom Disorder (DSM-5), Impairment, Psychological Factors, Persistent Physical Symptoms
University of Vienna
Not applicable
40
Vienna
2025-06-26
Recruiting
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
NCT06937086Ulcerative Colitis, Obesity or Overweight
DrugsMirikizumab·Tirzepatide
Eli Lilly and Company
Phase 3
350
Graz, Innsbruck, Vienna
2025-06-26
Recruiting
A Clinical Trial to Test the Safety, Tolerability, and How the Body Processes CPV-104 in Healthy People and Patients With C3-Glomerulopathy
NCT07483827C3 Glomerulopathy (C3G), Healthy Adult Participants
eleva GmbH
Phase 1
39
Vienna
2025-06-26
Recruiting
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
NCT06937099Crohn's Disease, Obesity or Overweight
DrugsMirikizumab·Tirzepatide
Eli Lilly and Company
Phase 3
290
Graz, Innsbruck, Vienna
2025-06-26
Recruiting
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
NCT07037459Heart Failure With Preserved Ejection Fraction, Heart Failure With Mildly Reduced Ejection Fraction, Obesity
DrugMaridebart cafraglutide
Amgen
Phase 3
5,056
Braunau am Inn, Graz, Klagenfurt, Linz, Salzburg, Sankt Pölten, Vienna
2025-06-25
Recruiting
INNODIA Family & Friends Early-Stage T1D Detection Protocol
NCT07118098Type 1 Diabetes (T1D), Pre Diabetes
INNODIA iVZW
Observational
30,000
Vienna
2025-06-25
Recruiting
Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
NCT06961214Pulmonary Disease, Chronic Obstructive
DrugDepemokimab
GlaxoSmithKline
Phase 3
960
Graz, Innsbruck, Klagenfurt, Linz, Vienna
2025-06-23
Recruiting
Impact on the Absorption of Drugs in Ostomy Patients
NCT07138326Stoma Ileostomy, Ileostomy - Stoma, Colostomy - Stoma, Absorption
WiGeV Klinik Ottakring
Observational
128
Vienna
2025-06-18
Active, closed
A Study to Assess the Change in Disease Activity in Adult Participants With Moderate to Severe Ulcerative Colitis Treated With Risankizumab Compared to Vedolizumab
NCT06880744Ulcerative Colitis
DrugsRisankizumab·Vedolizumab
AbbVie
Phase 3
573
Graz, Linz, Wels, Salzburg, Vienna
2025-06-17
Active, closed
A Phase 3 Study of Zodasiran in Adolescent and Adult Subjects With Homozygous Familial Hypercholesterolemia (YOSEMITE)
NCT07037771Homozygous Familial Hypercholesterolemia
Arrowhead Pharmaceuticals
Phase 3
70
Innsbruck, Linz, Vienna
2025-06-17
Recruiting
Gestational Diabetes and Health Outcomes in Mothers and Babies
NCT07459907Gestational Diabetes Mellitus (GDM), Pregnancy
Medical University of Graz
Observational
400
Graz
2025-06-15
Recruiting
A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)
NCT06943872Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
DrugsSonrotoclax·Venclexta·Obinutuzumab·Venetoclax
BeOne Medicines
Phase 3
630
Innsbruck, Vienna
2025-06-11
Recruiting
A Study to Learn More About the Effects and Long-Term Safety of Omaveloxolone (BIIB141) in Children and Teens With Friedreich's Ataxia
NCT06953583Friedreich Ataxia
DrugsSkyclarys·Omaveloxolone
Biogen
Phase 3
255
Innsbruck
2025-06-09
Recruiting
The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis
NCT06872892Bronchiectasis
DrugVerducatib
Boehringer Ingelheim
Phase 3
1,755
Graz, Innsbruck
2025-06-09
Active, closed
Effect of Music on Patient Comfort
NCT07206186Perioperative Anxiety
Medical University of Vienna
Not applicable
100
Vienna
2025-06-05
Recruiting
Exploratory Study on the Potential Cross-System Effects of BCI-FES Hand Therapy on Dysphagia and Aphasia in Chronic Stroke Patients
NCT06940635Ischaemic Stroke, Hemorrhagic Stroke
VASCage GmbH
Not applicable
10
Innsbruck
2025-06-04
Active, closed
A Study to Evaluate Axatilimab Versus Best Available Therapy in Participants With Chronic Graft Versus Host Disease After at Least 2 Prior Lines of Systemic Therapy
NCT06821542Chronic Graft-versus-host-disease
DrugAxatilimab
Incyte Corporation
Phase 3
9
Graz, Innsbruck, Linz, Vienna
2025-06-04
Recruiting
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
NCT06852222Leukemia, Myeloid, Acute
DrugsBleximenib·Azacitidine·Venetoclax
Janssen Research & Development, LLC
Phase 3
600
Linz, Salzburg, Vienna, Wels
2025-06-04
Recruiting
Initial Feasibility Study of the STENTiT Resorbable Fibrillated Scaffold (RFS). The RFS is Intended to Restore Lumen Patency and Blood Flow to Infrapopliteal Arteries. The RFS is a Fully Electrospun Tubular Device With a Fibrillated Microarchitecture and Designed for Transcatheter Delivery
NCT07006467Critical Limb Ischemia (CLI)
Stentit
Not applicable
10
Graz
2025-06-03
Active, closed
A First-in-human, Clinical Trial Assessing the Safety of ES2B-C001-S01 With or Without [Adjuvant] in Patients With HER2-expressing Metastatic Breast Cancer.
NCT06746688Breast Cancer, Breast Cancer Metastatic
ExpreS2ion Biotechnologies
Phase 1
40
Graz, Linz, Vienna
2025-06-03
Recruiting
Safety and Efficacy of OD-07656 and of Subsequent Vedolizumab Therapy in Moderately to Severely Active Ulcerative Colitis
NCT06850727Ulcerative Colitis (UC), UC - Ulcerative Colitis
DrugVedolizumab
Odyssey Therapeutics
Phase 2
57
Graz
2025-06-02
Recruiting
A Double Blind Study Performed to Evaluate the Efficacy and the Safety of EscharEx in Debridement of VLU (VALUE)
NCT06568627Venous Leg Ulcer (VLU)
DrugEscharEx
MediWound Ltd
Phase 3
216
Graz, Vienna
2025-06-01
By invitation
Cross-cultural Adaptation and Translation Validation of the iADH Universal Case Mix Tool (UCMT).
NCT07290725Dentistry
Sigmund Freud PrivatUniversitat
Observational
40
Vienna
2025-06-01
Recruiting
Implementation of an Empiric Transfusion Bundle for Out of Hospital Patients With Haemorrhagic Shock
NCT06891131Haemorrhagic Shock, Trauma Coagulopathy
Medical University of Graz
Observational
10
Graz
2025-06-01
Recruiting
Sarcopenia in Gestational Diabetes
NCT06876090Sarcopenia, Gestational Diabetes Mellitus (GDM), Pregnancy Complications, Adverse Maternal and Neonatal Outcomes
Istituto di Neuroscienze Consiglio Nazionale delle Ricerche
Observational
200
Vienna
2025-05-28
Recruiting
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
NCT07012395Ulcerative Colitis, Inflammatory Bowel Diseases, Colitis, Colitis, Ulcerative
DrugsSPY001·SPY002·SPY003
Spyre Therapeutics, Inc.
Phase 2
645
Linz
2025-05-27
Recruiting
EURO-STIM Registry
NCT06971796Obstructive Sleep Apnea, Obstructive Sleep Apnea (OSA)
Inspire Medical Systems, Inc.
Observational
1,000
Klagenfurt, Linz
2025-05-26
Recruiting
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
NCT06952504Endometrial Cancer
DrugsSacituzumab tirumotecan·Docetaxel·Paclitaxel·Cisplatin
Merck Sharp & Dohme LLC
Phase 3
1,123
Graz, Innsbruck, Vienna
2025-05-22
Recruiting
Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.
NCT06697301Advanced Melanoma
DrugsEIK1001·Keytruda·Pembrolizumab
Eikon Therapeutics
Phase 2/3
740
Graz
2025-05-22
Recruiting
Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab Administered Intravenously in Adult Participants at High Risk of Delayed Graft Function After Kidney Transplantation
NCT06830798Delayed Graft Function, DGF, Kidney Transplant
DrugRavulizumab
Alexion Pharmaceuticals, Inc.
Phase 3
450
Innsbruck, Vienna
2025-05-19
Recruiting
Validity of ICU Clinician's Appraisal of Proportionality in CPR
NCT07026773Cardiac Arrest, Out-Of-Hospital
University Hospital, Ghent
Observational
1,000
Innsbruck
2025-05-18
Recruiting
Surgical vs Transcatheter Aortic Valve Replacement in YOUNG Patients
NCT06861361Symptomatic Severe Aortic Stenosis
Ceric Sàrl
Not applicable
1,180
Graz, Sankt Pölten, Vienna
2025-05-15
Recruiting
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
NCT06925737Prostate Cancer, Prostatic Neoplasms
DrugsIfinatamab Deruxtecan·Prednisone·Docetaxel
Merck Sharp & Dohme LLC
Phase 3
1,440
Linz, Wels, Salzburg
2025-05-13
Recruiting
ZeroHeart Biopsy - Prediction of Deceased Donor Heart Transplant Performance From Organ Donors Using Pre-Transplant Biopsies - A Pilot Study
NCT06982404Heart Transplantation, Graft Rejection, Myocardial Injury, Organ Preservation
Medical University of Vienna
Observational
50
Vienna
2025-05-12
Recruiting
Effect of Dynamic Sitting on Pain Development - Part 2
NCT07197879Lower Back Pain
University of Applied Sciences for Health Professions Upper Austria
Not applicable
20
Linz
2025-05-12
Recruiting
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
NCT06819891Moderately to Severely Active Crohns Disease
DrugAfimkibart
Hoffmann-La Roche
Phase 3
425
Linz, Wels
2025-05-12
Recruiting
Urinary Microbiome as a Biomarker for Melanoma Diagnosis and Response Prediction to Systemic Tumour Therapy
NCT07635732Melanoma Stage IV
Medical University of Graz
Observational
50
Gratwein
2025-05-08
Active, closed
FARAPULSE Workflow Assessment Registry
NCT06656884Atrial Fibrillation (AF)
Boston Scientific Corporation
Observational
524
Linz
2025-05-06
Recruiting
Revumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or KMT2A-rearranged AML
NCT06652438Acute Myeloid Leukemia, Adult
DrugRevumenib
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
448
Feldkirch, Linz, Salzburg, Vienna
2025-05-05
Recruiting
Metabolic Control of Aging and Disease - the MetAGE Deep Phenotyping Cohort
NCT06511297Obesity, Aging, Aging Problems, Metabolic Syndrome
Thomas Scherer
Observational
650
Vienna, Graz
2025-05-05
Recruiting
Metabolome and Gut Microbiome Changes During Smoking Cessation in Long-term Drug Therapy in a Therapeutic Community
NCT06803706Substance Use Disorder (SUD), Alcohol Use Disorder (AUD), Nicotine Addiction, Healthy Adult Participants
Sigmund Freud PrivatUniversitat
Not applicable
150
Fehring, Graz, Vienna
2025-05-05
Recruiting
PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis
NCT06855329Progressive Pulmonary Fibrosis, Interstitial Lung Disease
University of Massachusetts, Worcester
Observational
500
Graz
2025-05-01
Recruiting
Innsbruck Health Promotion Program
NCT06813677Assessment of Vascular Health Risk Factors
VASCage GmbH
Not applicable
1,000
Innsbruck
2025-05-01
Recruiting
Non-interventional Study to Assess the Number of People With Untreated/Unknown HBV + HDV and HCV in South-East Austria
NCT06834178HBV, HCV, HDV, Coinfection
Vanessa Stadlbauer-Koellner, MD
Observational
100
Graz
2025-05-01
Recruiting
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
NCT06875310Carcinoma, Non-Small-Cell Lung
DrugsAdagrasib·Pemetrexed·Cisplatin·Carboplatin
Mirati Therapeutics Inc.
Phase 3
630
Graz, Wels, Linz, Vienna
2025-04-24
Recruiting
A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer
NCT06820463Metastatic Colorectal Cancer
DrugsTelisotuzumab Adizutecan·Panitumumab·Leucovorin·Fluorouracil
AbbVie
Phase 2
390
Salzburg, Vienna
2025-04-24
Recruiting
Study of Plozasiran in Adults With Severe Hypertriglyceridemia at Risk of Acute Pancreatitis
NCT06880770Severe Hypertriglyceridemia
DrugPlozasiran
Arrowhead Pharmaceuticals
Phase 3
288
Graz, Linz, Vienna
2025-04-24
Active, closed
A Study to Assess Efficacy and Safety of JNJ-77242113 Compared to Placebo and Ustekinumab in Participants With Moderate to Severe Plaque Psoriasis
NCT06934226Plaque Psoriasis
DrugsIcotrokinra·Ustekinumab
Janssen Research & Development, LLC
Phase 3
752
Feldkirch, Linz, Sankt Pölten, Vienna
2025-04-15
Recruiting
Study on Practical ExperienceS of Treatment With Foslevodopa/foScaRbidopa in Advanced Parkinson's Disease
NCT06937034Parkinson's Disease
AbbVie
Observational
2,000
Graz
2025-04-14
Recruiting
A Contrast Medium Sparing Strategy Using Automated CO2 Injection During PVI for Prevention of Major Adverse Kidney Events (MAKE)
NCT06656988Peripheral Vascular Diseases, Kidney Diseases
University of Leipzig
Phase 3
1,960
Innsbruck, Vienna
2025-04-14
Recruiting
Personalized Monitoring of Non-foveal, Non-vision Compromising Atrophic Age-related Macular Degeneration With Artificial Intelligence and Identification of Disease Progression
NCT06351657Age-Related Macular Degeneration, Geographic Atrophy
Medical University of Vienna
Observational
200
Vienna
2025-04-11
Recruiting
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
NCT06824467Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer
DrugsSteroid mouthwash (dexamethasone·Mvasi·Acetaminophen·Avastin
Merck Sharp & Dohme LLC
Phase 3
770
Vienna, Graz, Innsbruck
2025-04-09
Recruiting
Oral Lactobacillus Supplementation as Treatment for Overactive Bladder Syndrome: A Randomised Controlled Trial
NCT06546189Overactive Bladder Syndrome
Medical University of Vienna
Not applicable
100
Vienna
2025-04-01
Recruiting
Comparison of Customized Allogenic Versus Autogenous Bone Block Graft for Alveolar Ridge Augmentation
NCT07419269Alveolar Bone Loss
Medical University of Graz
Not applicable
26
Graz
2025-04-01
Recruiting
The Dragon PLC Trial (DRAGON-PLC)
NCT06914648Primary Liver Cancer, Hepatocellular Carcinoma (HCC), Cholangiocarcinoma
Maastricht University
Not applicable
358
Vienna
2025-04-01
Not yet open
Brillouin Microscopy Used to Evaluate Corneal Mechanical Properties
NCT06914817Map Dot Fingerprint Dystrophy, Post-penetrating Keratoplasty, Post-Descemet Membrane Endothelial Keratoplasty, Healthy Corneas
Vienna Institute for Research in Ocular Surgery
Not applicable
100
Vienna
2025-04-01
Not yet open
Effect of Alpha-1 Antitrypsin Supplementation on Alcohol-Associated Hepatitis
NCT06582329Alcohol-Associated Hepatitis
Medical University Innsbruck
Phase 2
16
Innsbruck
2025-04
Recruiting
Nitrate, Exercise and Vascular Function in Midlife Women
NCT06527248Healthy, Menopause, Hypertension, Inflammation
University of Vienna
Not applicable
54
Vienna
2025-03-31
Rows per page Showing 301–400 of 1573
Previous 2 3 4 5 6 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Austrian investigative site. Derived from ClinicalTrials.gov. Retrieved 28 September 2026. https://priyalifescience.com/clinical-trials-austria?page=4

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Austria and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 1,573 studies in total at the last sync on 26 Sep 2026, 19:45 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

How many clinical trials are recruiting in Austria?

850 of the 1,573 studies in this register are recruiting new participants as of the 26 Sep 2026, 19:45 UTC sync. A further 89 have not yet opened recruitment, 590 are active but closed to new participants, and 44 are enrolling by invitation only. Eligibility for any study is decided by its study team.

This register, in your inbox every Friday

One email a week with how many trials are recruiting in Ireland, new EMA and FDA approvals and medicine shortages, built from the same public registers as this page.

Free. Unsubscribe from any email with one click. See our privacy policy.

→

Browse trials by condition

Breast Cancer (24) Multiple Myeloma (18) Ulcerative Colitis (18) Heart Failure (16) Crohn's Disease (15) Coronary Artery Disease (14) Atrial Fibrillation (14) Chronic Lymphocytic Leukemia (13) Non-small Cell Lung Cancer (12) Obesity (11) Non-Small Cell Lung Cancer (11) Cataract (11) Acute Myeloid Leukemia (10) Carcinoma, Non-Small-Cell Lung (10) Pulmonary Hypertension (9)
→

Browse trials by site location

Vienna (1005) Graz (506) Linz (438) Innsbruck (398) Salzburg (291) Sankt Pölten (113) Wels (92) Klagenfurt (62) Feldkirch (49) Krems (34) Wiener Neustadt (33) Leoben (27) Rankweil (24) Braunau am Inn (17) Steyr (14)
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.